• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

Scooby69's Profile

Avatar:

Membership:

Premium

Person Marks:

0

Total Posts:

9

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

0

Alias Born

03/28/2017 3:46:02 PM

Personal info

Recent Articles

• Royalty Pharma's Latest Dividend Increase: What You Need to Know
• Wabash Celebrates Recognition as a Leading Responsible Company
• Understanding Voting Rights and Share Capital Basics
• Enact Holdings, Inc. Sets Earnings Call for Early February
• Intellia Therapeutics Focuses on Late-Stage Drug Advancements
• Mural Oncology's Pipeline Progress and 2025 Outlook
• Aptose Unveils Promising New Therapy for AML Patients
• Zefiro Methane Corp. Showcases Growth with New Corporate Insights
• Innovative Timing Solutions: Frequency Electronics at Needham
• Discover PagerDuty's Upcoming Presentation at Key Investment Event
• Diamondback Energy Announces Fourth Quarter Financial Call
• Viper Energy Plans Q4 2024 Results Call for Investors
• FORE Biotherapeutics Unveils Ambitious Pipeline Goals for 2025
• Highwoods Properties Set to Release Impressive Q4 2024 Results
• Kim Macaulay Joins Identiv as Senior Vice President of Sales
• ImmuCell Reports Impressive Sales Growth for Year-End Results
• Elevance Health Announces Conference Call for Q4 and Year-End Results
• Brookline Bancorp Reveals Earnings Call Details for Q4 2024
• JFrog Financial Results Announcement and Future Insights
• ResMed's Upcoming Earnings: What Investors Should Know
• FrontView REIT Provides Exciting Business Updates and Plans Ahead
• LPL Financial's Upcoming Earnings Release and Highlights
• Marea Therapeutics Reveals Exciting Milestones in Drug Development
• Phillips Edison & Company Expands Financing With Major Credit Facility
• QIAGEN Launches Innovative Gastrointestinal Testing Panel
• Dave Inc. to Showcase Innovations at Upcoming Conference
• Repare Therapeutics Shifts Focus to Key Cancer Treatments
• Gatos Silver Achieves Record Production Results for 2024
• Reinsurance Group of America Reveals Earnings Call Plans
• Transocean Ltd. Investors Can Join Major Class Action Lawsuit
• Radian Group's Real Estate Management Receives Key Approval
• SkyWest, Inc. Prepares for Upcoming Q4 & Year End 2024 Conference
• Canso Credit Income Fund Announces Special Distributions This Year
• Atlassian Schedules Second Quarter Financial Results Meeting
• Block Inc. Unveils New Ticker Symbol to Enhance Branding
• Rising Concerns for Investors in Rigetti Computing, Inc. Securities
• Enhancing Patient Care: Florida Cancer Specialists' New Strategies
• Cullen/Frost Bankers Announces Q4 2024 Earnings Call Details
• Orna Therapeutics Strengthens Leadership with New Board Member
• Revance Therapeutics Faces Class Action: Join the Fight Today
• Innocan Pharma Celebrates FDA Fee Waiver for Innovative Treatment
• Unlocking Microsoft's Financial Insights: Upcoming Earnings Call
• MongoDB, Inc. to Showcase Innovations at Upcoming Conference
• Leadership Change at TriNetX Marks New Era for Innovation
• Biglari Holdings Inc. Announces 2025 Annual Shareholders Meeting
• Stellus Capital Announces Quarterly Dividend of $0.40 for Shareholders
• Stellus Private Credit BDC Declares $0.36 Dividend for Q1 2025
• Authors Accuse Meta of Using Unauthorized Books for AI Training
• Smartmatic's $2.7 Billion Lawsuit Against Fox News Moves Forward
• Chevron's Commitment to Democracy Through Inaugural Support